scroll down the page to go through
each element in order

or

pick one to jump to it

Dismiss Instructions

proteins-diagram

Function

The HCV core is a structural protein that aggregates to form the viral capsid, a spherical structure that surrounds and protects the viral genomic RNA. The core protein is the first protein to be translated from the HCV genome and together with the envelope glycoproteins (E1 and E2) comprise the three structural HCV proteins. As a component of the nucleocapsid structure, the mature core protein has properties that promote binding to the host-derived lipid membrane and HCV RNA. The N-terminal region of the core proteins bind to the HCV genomic RNA. 

Structure Details

The initial cleavage of the core by a host signal peptidase generates an immature core protein that is 191 amino acids long. A second cleavage by a signal peptide peptidase removes the C-terminal E1 signal sequence, releasing the mature core protein that is 177 amino acids long and 21-kDa in weight. The mature core protein is composed of two distinct domains: D1 (at the N-terminal region) and D2 (at the C-terminal region). The D1 domain is highly flexible in structure and subdivided into three basic domains (BD): BD1, BD2, and BD3. During assembly, the D1 domain is involved in RNA binding and oligomerization (around the RNA scaffolding) to form the nucleocapsid. The D2 domain contains the Helix I and Helix II regions, which are connected by a hydrophobic loop, and contributes to interactions with lipid membranes. The D3 domain corresponds to the extreme C-terminal region that is cleaved and therefore is absent in the mature capsid protein.
BD = Basic Domain; H = Helix; HL = Hydrophobic Loop
Figure 1. Core Protein
BD = Basic Domain; H = Helix; HL = Hydrophobic Loop
6 References
  • Eng FJ, El-Shamy A, Doyle EH, Klepper A, Muerhoff AS, Branch AD. Newly discovered hepatitis C virus minicores circulate in human blood. Hepatol Commun. 2018;2:21-8.
  • Gawlik K, Gallay PA. HCV core protein and virus assembly: what we know without structures. Immunol Res. 2014;60:1-10.
  • Kao CC, Yi G, Huang HC. The core of hepatitis C virus pathogenesis. Curr Opin Virol. 2016;17:66-73.
  • Klein KC, Polyak SJ, Lingappa JR. Unique features of hepatitis C virus capsid formation revealed by de novo cell-free assembly. J Virol. 2004;78:9257-69.
  • Rupp D, Bartenschlager R. Targets for antiviral therapy of hepatitis C. Semin Liver Dis. 2014;34:9-21.
  • Strosberg AD, Kota S, Takahashi V, Snyder JK, Mousseau G. Core as a novel viral target for hepatitis C drugs. Viruses. 2010;2:1734-51.

Function

The envelope glycoprotein E1 protein is a highly glycosylated transmembrane protein that tightly associates with the E2 glycoprotein to form the envelope glycoprotein E1-E2 heterodimer. The E1 protein plays a role in multiple steps in the HCV replication cycle, including attachment to the host cell, endosome-lipid membrane fusion, and assembly. The role for E1 in attachment may involve binding to host apoproteins or possibly CD36. In addition, E1 assists E2 as it binds with host receptors by maintaining an E1-E2 structural conformation favorable for receptor binding. Following endocytosis of the HCV particle, the acidic environment in the endosome stimulates conformational changes in E1 and E2, which generates fusion of the endosomal membrane with the viral envelope and release of the HCV RNA into the cytoplasm. Recent studies also suggest the E1 protein interacts with several other viral proteins to coordinate the HCV assembly process.

Structure Details

E1 is a type I transmembrane protein that has a molecular weight of 23 kDa and is 192 amino acids long. The E1 protein has four main domains: an N-terminal domain (NTD), a putative fusion peptide (pFP), a conserved region (CR), and a short C-terminal transmembrane domain (TMD). The E1 protein contains 4-5 N-linked glycans. On the surface of HCV, most of the E1 immunogenic domains are hidden below E2 in the E1-E2 heterodimer, which explains why the E1 proteins are considered significantly less immunogenic than E2 proteins. The E1 highly conserved GxxxG motif (Gly354 and Gly358), which is located in the transmembrane domain plays an essential role in the formation of the E1 trimer. In addition, the CxxC motif (Cys 226 and Cys 229), appears to play a role during virus entry.
Note: the gray numbers and symbols indicate glycosylation sites
NTD = N-terminal Domain; pFP = putative Fusion Peptide; CR = Conserved Region; TMD = Transmembrane Domain
Figure 1. E1_Protein
Note: the gray numbers and symbols indicate glycosylation sites NTD = N-terminal Domain; pFP = putative Fusion Peptide; CR = Conserved Region; TMD = Transmembrane Domain
7 References
  • El Omari K, Iourin O, Kadlec J, et al. Unexpected structure for the N-terminal domain of hepatitis C virus envelope glycoprotein E1. Nat Commun. 2014;5:4874.
  • Haddad JG, Rouillé Y, Hanoulle X, et al. Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly. J Virol. 2017;91:pii: e00048-17.
  • Law JL, Chen C, Wong J, et al. A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans. PLoS One. 2013;8:e59776.
  • Mazumdar B, Banerjee A, Meyer K, Ray R. Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes. Hepatology. 2011;54:1149-56.
  • Moustafa RI, Haddad JG, Linna L, et al. Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain. J Virol. 2018;92:pii: e00939-18.
  • Tong Y, Lavillette D, Li Q, Zhong J. Role of Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly. Front Immunol. 2018;9:1411.
  • Yost SA, Wang Y, Marcotrigiano J. Hepatitis C Virus Envelope Glycoproteins: A Balancing Act of Order and Disorder. Front Immunol. 2018;9:1917.

Function

The envelope glycoprotein E2 protein is a heavily glycosylated transmembrane protein that associates with the E1 envelope glycoprotein to form E1-E2 heterodimers. These E1-E2 heterodimers are embedded in the host-derived lipid membrane and together they form the HCV envelope. The E2 protein has an elongated shape and plays a role in host receptor binding, entry, and fusion with the endosomal membrane. The E2 protein binds to several host cell surface receptors, including CD81 and scavenger receptor class B type 1 (SR-B1).

Structure Details

The E2 protein has a molecular weight of 70 kDa and is 363 amino acids long. The E2 protein contains hypervariable region 1 (HVR1), HVR2, intergenotypic variable region (igVR), a stem region, and a transmembrane (TM) domain. The E2 protein undergoes N-linked glycosylation at 9 to 11 sites and has 18 conserved cysteine residues; this process is important for proper protein folding and immune evasion. The heavily glycosylated regions on E2 contain immunodominant neutralization epitopes that are believed to function as immunological decoys to shield more conserved neutralization epitopes. Although genetic heterogeneity can be found throughout the HCV genome, the N-terminus of the E2 glycoprotein can be highly variable and change rapidly even within a patient.
Note: the gray numbers and symbols indicate glycosylation sites; HVR = Hypervariable Region; NT = N-terminal; IgVR = Intergenotypic Variable Region; TM = Transmembrane
Figure 1. E2_Protein
Note: the gray numbers and symbols indicate glycosylation sites; HVR = Hypervariable Region; NT = N-terminal; IgVR = Intergenotypic Variable Region; TM = Transmembrane
9 References
  • Albecka A, Montserret R, Krey T, et al. Identification of new functional regions in hepatitis C virus envelope glycoprotein E2. J Virol. 2011;85:1777-92.
  • Drummer HE. Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies. Front Microbiol. 2014;5:329.
  • Fauvelle C, Felmlee DJ, Baumert TF. Unraveling hepatitis C virus structure. Cell Res. 2014;24:385-6.
  • Freedman H, Logan MR, Law JL, Houghton M. Structure and Function of the Hepatitis C Virus Envelope Glycoproteins E1 and E2: Antiviral and Vaccine Targets. ACS Infect Dis. 2016;2:749-762.
  • Khan AG, Whidby J, Miller MT, et al. Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2. Nature. 2014;509:381-4.
  • Kong L, Giang E, Nieusma T, et al. Hepatitis C virus E2 envelope glycoprotein core structure. Science. 2013;342:1090-4.
  • Prentoe J, Velázquez-Moctezuma R, Foung SK, Law M, Bukh J. Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity. Hepatology. 2016;64:1881-92.
  • Sabahi A, Uprichard SL, Wimley WC, Dash S, Garry RF. Unexpected structural features of the hepatitis C virus envelope protein 2 ectodomain. J Virol. 2014;88:10280-8.
  • Vieyres G, Dubuisson J, Pietschmann T. Incorporation of hepatitis C virus E1 and E2 glycoproteins: the keystones on a peculiar virion. Viruses. 2014;6:1149-87.

Function

The p7 protein is a small, hydrophobic transmembrane protein that participates in viral assembly and release. The p7 protein can oligomerize as hexamers to form ion channels in host cell membranes—based on this property, p7 is categorized in the viroporin family of proteins. Although p7 has a structural role inside hepatocytes, it is not part of the viral particle. During assembly, the p7 proteins work in concert with other viral proteins at the endoplasmic reticulum to unload core proteins from lipid droplets for capsid assembly and membrane envelopment. The p7 channel activity can dissipate the low pH of the cellular secretory compartment thus protecting the viral glycoprotein from inactivation.

Structure Details

The p7 protein has a molecular weight of only 7 kDa and is only 63 amino acids long. The protein consists of an N-terminal region, transmembrane domain 1 (TM1), a short loop, transmembrane domain 2 (TM2), and a C-terminal end. The N-terminal and C-terminal regions of p7 are both oriented toward the endoplasmic reticulum lumen, whereas the short, intervening loop extends into the cytoplasm. The TM1 and TM2 domains are alpha helixes. The p7 oligomers have been identified in heptameric and hexameric forms. 
7 References
  • Atoom AM, Taylor NG, Russell RS. The elusive function of the hepatitis C virus p7 protein. Virology. 2014;462-463:377-87.
  • Chandler DE, Penin F, Schulten K, Chipot C. The p7 protein of hepatitis C virus forms structurally plastic, minimalist ion channels. PLoS Comput Biol. 2012;8:e1002702.
  • Denolly S, Mialon C, Bourlet T, et al. The amino-terminus of the hepatitis C virus (HCV) p7 viroporin and its cleavage from glycoprotein E2-p7 precursor determine specific infectivity and secretion levels of HCV particle types. PLoS Pathog. 2017;13:e1006774.
  • Gentzsch J, Brohm C, Steinmann E, et al. hepatitis c Virus p7 is critical for capsid assembly and envelopment. PLoS Pathog. 2013;9:e1003355.
  • Khaliq S, Jahan S, Hassan S. Hepatitis C virus p7: molecular function and importance in hepatitis C virus life cycle and potential antiviral target. Liver Int. 2011;31:606-17.
  • Madan V, Bartenschlager R. Structural and Functional Properties of the Hepatitis C Virus p7 Viroporin. Viruses. 2015;7:4461-81.
  • OuYang B, Xie S, Berardi MJ, et al. Unusual architecture of the p7 channel from hepatitis C virus. Nature. 2013;498:521-5.

Function

The nonstructural protein 2 (NS2) has dual functions in the HCV life cycle—as a cysteine protease and as a cofactor in the assembly process. The protease domain of the NS2 protein, in cooperation with the N-terminal region of NS3, functions as a cysteine protease to catalyze a single cleavage between the NS2 and NS3 proteins. The freeing of the NS2 from NS3 is essential for RNA replication. The NS2 protein is not required for HCV RNA replication, but in conjunction with multiple other viral proteins, it plays a key role in coordinating viral assembly. Specifically, it appears that during viral assembly, NS2 colocalizes with E1, E2, NS3, and NS5A near the core proteins and lipid droplet.

Structure Details

The dimeric NS2 protein has a molecular weight of 21 kDa and is 217 amino acids long. NS2 has three transmembrane domains, a small alpha helix, and a protease domain (that faces the cytosol). The NS2 protein has two active sites and functions as a cysteine protease, with its C-terminal domain (cleaving the NS2-NS3 junction in coordination with the N-terminal 180 amino acids of the NS3 protein. The protease domain forms a dimer that consists of an N-terminal alpha-helical subdomain and a domain-swapped C-terminal antiparallel beta sheet. The protease domain houses catalytic activity in the C-terminal at the catalytic triad: His 143, Glu 163, and Cys 184. The N-terminal transmembrane segment of NS2 is the region thought to play a central role in HCV particle assembly.
TM = Transmembrane
Figure 1. NS2_Protein
TM = Transmembrane
6 References
  • Jirasko V, Montserret R, Appel N, et al. Structural and functional characterization of nonstructural protein 2 for its role in hepatitis C virus assembly. J Biol Chem. 2008;283:28546-62.
  • Jones CT, Murray CL, Eastman DK, Tassello J, Rice CM. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J Virol. 2007;81:8374-83.
  • Lorenz IC, Marcotrigiano J, Dentzer TG, Rice CM. Structure of the catalytic domain of the hepatitis C virus NS2-3 protease. Nature. 2006;442:831-5.
  • Lorenz IC. The Hepatitis C Virus Nonstructural Protein 2 (NS2): An Up-and-Coming Antiviral Drug Target. Viruses. 2010;2:1635-46.
  • Popescu CI, Callens N, Trinel D, et al. NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly. PLoS Pathog. 2011;7:e1001278.
  • Yi M, Ma Y, Yates J, Lemon SM. Trans-complementation of an NS2 defect in a late step in hepatitis C virus (HCV) particle assembly and maturation. PLoS Pathog. 2009;5:e1000403.

Function

The nonstructural 3 (NS3) protein is a bifunctional enzyme that has serine protease and helicase activity. The serine-type protease region of NS3 is responsible for most of the cleavages of the viral polyprotein that free nonstructural proteins. In addition, NS3 plays a role in subverting the innate host immune response by proteolytically inactivating various host cell factors that can block viral replication. The helicase region of N3 likely plays a role unwinding the viral RNA and supporting viral replication. One of the first advances in the development of direct-acting antiviral therapy was solving the crystal structure of the NS3 protease which allowed the design of specific NS3/4A protease inhibitors.

Structure Details

The NS3 protein has a molecular weight of 70kDa and is 631 amino acids long. The protein has two major domains: (1) the serine protease domain in N-terminal region (180 amino acids long) and (2) the larger nucleoside-triphosphatase-dependent RNA helicase domain in the C-terminal region that is 450 amino acids long. The N-terminal domain contains the protease catalytic triad at highly conserved amino acid positions (Histidine-57, Aspartate-81, and Serine-139); the serine protease is stabilized by a Zn2+ atom. At the membrane, the NS3 protein is anchored by the 54-amino-acid NS4 protein and together they form the NS3-4A enzyme complex.
6 References
  • Brass V, Berke JM, Montserret R, Blum HE, Penin F, Moradpour D. Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex. Proc Natl Acad Sci U S A. 2008;105:14545-50.
  • De Francesco R, Pessi A, Steinkühler C. Mechanisms of hepatitis C virus NS3 proteinase inhibitors. J Viral Hepat. 1999;6 Suppl 1:23-30.
  • Love RA, Parge HE, Wickersham JA, et al. The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell. 1996;87:331-42.
  • Morikawa K, Lange CM, Gouttenoire J, et al. Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus. J Viral Hepat. 2011;18:305-15.
  • Raney KD, Sharma SD, Moustafa IM, Cameron CE. Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target. J Biol Chem. 2010;285:22725-31.
  • Rupp D, Bartenschlager R. Targets for antiviral therapy of hepatitis C. Semin Liver Dis. 2014;34:9-21.

Function

The nonstructural protein 4a (NS4A) is the smallest of the nonstructural HCV proteins. The NS4A protein has multiple functions in the HCV life cycle, including (1) anchoring the NS3-4A complex to the outer leaflet of the endoplasmic reticulum and mitochondrial outer membrane, (2) serving as a cofactor for the NS3A serine protease, (3) augmenting NS3A helicase activity, and (4) regulating NS5A hyperphosphorylation and viral replication. The interactions between NS4A and NS4B control genome replication and between NS3 and NS4A play a role in virus assembly.

Structure Details

The NS4A protein is the smallest of the nonstructural HCV proteins—it is 27 kDa in weight and is 54 amino acids in length. The NS4A protein has three domains: (1) N-terminal hydrophobic portion that forms a transmembrane alpha-helix essential for the integral membrane association of the NS3-4A complex, (2) a central region that is required for proper folding of NS3, and (3) a C-terminal acidic portion that comprises a highly negatively charged α-helix involved in regulating NS5A hyperphosphorylation and viral replication.
6 References
  • Brass V, Berke JM, Montserret R, Blum HE, Penin F, Moradpour D. Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex. Proc Natl Acad Sci U S A. 2008;105:14545-50.
  • Lin C, Wu JW, Hsiao K, Su MS. The hepatitis C virus NS4A protein: interactions with the NS4B and NS5A proteins. J Virol. 1997;71:6465-71.
  • Lindenbach BD, Prágai BM, Montserret R, et al. The C terminus of hepatitis C virus NS4A encodes an electrostatic switch that regulates NS5A hyperphosphorylation and viral replication. J Virol. 2007;81:8905-18.
  • Morikawa K, Lange CM, Gouttenoire J, et al. Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus. J Viral Hepat. 2011;18:305-15.
  • Phan T, Kohlway A, Dimberu P, Pyle AM, Lindenbach BD. The acidic domain of hepatitis C virus NS4A contributes to RNA replication and virus particle assembly. J Virol. 2011;85:1193-204.
  • Zhu H, Briggs JM. Mechanistic role of NS4A and substrate in the activation of HCV NS3 protease. Proteins. 2011;79:2428-43.

Function

Nonstructural protein 4B (NS4B) is a protein that induces alternations in the cytoplasmic membrane and mediates virus-host interactions; this protein co-localizes to the endoplasmic reticulum, along with other non-structural proteins, to forms the replication complex. The NS4B protein is one of several viral components essential to the formation of the membranous web, a microenvironment within the cytoplasm that supports viral replication.

Structure Details

The hydrophobic NS4B protein is 27kDa in size and 261 amino acids long. This hydrophobic protein has a complex structure consisting of an N-terminal helix in the endoplasmic reticulum lumen, a central region consisting of four-five transmembrane segments, and a C-terminal region in the cytosolic lumen that contains several helices. Prior to proteolytic cleavage, the NS4B is attached to NS4A, with both N-terminal and C-terminal components located in the cytosolic lumen (flanking four transmembrane NS4B segments). Following the NS34A cleavage of the NS4A and NS4B, the N-terminal region flips into the endoplasmic reticulum lumen.
AH = Amphipathic HelixH = Helix; TM = Transmembrane
Figure 1. NS4B_Protein
AH = Amphipathic Helix H = Helix; TM = Transmembrane
5 References
  • Esser-Nobis K, Romero-Brey I, Ganten TM, et al. Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B. Hepatology. 2013;57:953-63.
  • Gouttenoire J, Penin F, Moradpour D. Hepatitis C virus nonstructural protein 4B: a journey into unexplored territory. Rev Med Virol. 2010;20:117-29.
  • Lundin M, Lindström H, Grönwall C, Persson MA. Dual topology of the processed hepatitis C virus protein NS4B is influenced by the NS5A protein. J Gen Virol. 2006;87:3263-72.
  • Paul D, Hoppe S, Saher G, Krijnse-Locker J, Bartenschlager R. Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment. J Virol. 2013;87:10612-27.
  • Rai R, Deval J. New opportunities in anti-hepatitis C virus drug discovery: targeting NS4B. Antiviral Res. 2011;90:93-101.

Function

Nonstructural protein 5A (NS5A) is an essential component of the HCV replication complex. The NS5a protein interacts with other key viral products (NS4B, NS5B, RNA) and host cell proteins (cyclophilin A, kinases, etc.) to regulate viral replication and assembly. The NS5A protein plays a critical role in the formation of endoplasmic reticulum-derived double-membrane vesicles (DMVs), which facilitates efficient viral replication. In addition to its role in HCV replication, the NS5A protein also contributes to HCV pathogenesis, modulation of cell signaling pathways, virus propagation and response to interferon via the interferon-alfa sensitivity determining region.The direct-acting antiviral agent class NS5A inhibitors target the NS5A protein.

Structure Details

The NS5A protein is a zinc-binding and proline-rich hydrophilic phosphoprotein that is 56 kDa in weight and 448 amino acids long. The NS5A consists of four main regions: N-terminal amphipathic helix, Domain I, Domain II, and Domain III. In addition, low complexity sequences (LCIS1 and LCIS2) are interspersed between the three domains. Within hepatocytes infected with HCV, the NS5A protein localizes to the endoplasmic reticulum (ER) where it forms virus–induced multiple-membrane vesicles; in this region, known as the membranous web, the multiple-membrane vesicle hosts RNA replication complexes and lipid droplets.
AH = Amphipathic Helix; LCS = Low Complexity Sequence
Figure 1. NS5A_Protein
AH = Amphipathic Helix ; LCS = Low Complexity Sequence
8 References
  • Appel N, Zayas M, Miller S, et al. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog. 2008;4:e1000035.
  • Berger C, Romero-Brey I, Radujkovic D, et al. Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication. Gastroenterology. 2014;147:1094-105.e25.
  • Bukh J. The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control. J Hepatol. 2016;65:S2-S21.
  • Dustin LB, Rice CM. Flying under the radar: the immunobiology of hepatitis C. Annu Rev Immunol. 2007;25:71-99.
  • Morozov VA, Lagaye S. Hepatitis C virus: Morphogenesis, infection and therapy. World J Hepatol. 2018;10:186-212.
  • Romero-Brey I, Berger C, Kallis S, et al. NS5A Domain 1 and Polyprotein Cleavage Kinetics Are Critical for Induction of Double-Membrane Vesicles Associated with Hepatitis C Virus Replication. MBio. 2015;6:e00759.
  • Yin C, Goonawardane N, Stewart H, Harris M. A role for domain I of the hepatitis C virus NS5A protein in virus assembly. PLoS Pathog. 2018;14:e1006834.
  • Zayas M, Long G, Madan V, Bartenschlager R. Coordination of Hepatitis C Virus Assembly by Distinct Regulatory Regions in Nonstructural Protein 5A. PLoS Pathog. 2016;12:e1005376.

Function

Nonstructural protein 5B (NS5B) is an RNA-dependent RNA polymerase (RdRp) that plays a critical role in HCV replication. The function of this enzyme is to catalyze the polymerization of ribonucleoside triphosphates (rNTP) during viral RNA replication. There are two main subclasses of NS5B polymerase inhibitors: (1) nucleotide analogues that mimic the natural substrate and induce chain termination when incorporated into the new RNA and (2) non-nucleotide inhibitors that bind to the allosteric sites on the enzyme and impair its function.

Structure Details

The NS5B protein is 66 kDa in weight and 591 amino acids long. Similar to with other polymerases, NS5B has a conformation resembling a right hand with finger, palm, and thumb subdomains, with the enzyme conforming to a closed configuration during RNA synthesis and an open state during RNA elongation. The catalytic domain is formed by the N-terminal 530 amino acids. The HCV NS5B polymerase is structurally distinct from human cellular DNA and RNA polymerase enzymes. The NS5B protein contains the Gly-Asp-Asp motif in its active site and this region is binds magnesium, a process essential for enzymatic activity.
β-HP = β-Hairpin; C-TL= C-Terminal Linker
Figure 1. NS5B_Protein
β-HP = β-Hairpin; C-TL= C-Terminal Linker
9 References
  • Ago H, Adachi T, Yoshida A, et al. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Structure. 1999;7:1417-26.
  • Appleby TC, Perry JK, Murakami E, et al. Viral replication. Structural basis for RNA replication by the hepatitis C virus polymerase. Science. 2015;347:771-5.
  • Boyce SE, Tirunagari N, Niedziela-Majka A, et al. Structural and regulatory elements of HCV NS5B polymerase--β-loop and C-terminal tail--are required for activity of allosteric thumb site II inhibitors. PLoS One. 2014;9:e84808.
  • Lesburg CA, Cable MB, Ferrari E, Hong Z, Mannarino AF, Weber PC. Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat Struct Biol. 1999;6:937-43.
  • Lohmann V, Roos A, Körner F, Koch JO, Bartenschlager R. Biochemical and structural analysis of the NS5B RNA-dependent RNA polymerase of the hepatitis C virus. J Viral Hepat. 2000;7:167-74.
  • Love RA, Parge HE, Yu X, et al. Crystallographic identification of a noncompetitive inhibitor binding site on the hepatitis C virus NS5B RNA polymerase enzyme. J Virol. 2003;77:7575-81.
  • Mosley RT, Edwards TE, Murakami E, et al. Structure of hepatitis C virus polymerase in complex with primer-template RNA. J Virol. 2012;86:6503-11.
  • Soriano V, Vispo E, de Mendoza C, et al. Hepatitis C therapy with HCV NS5B polymerase inhibitors. Expert Opin Pharmacother. 2013;14:1161-70.
  • Thueng-in K, Thanongsaksrikul J, Jittavisutthikul S, et al. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase. MAbs. 2014;6:1327-39.

References

HCV Proteins

    Core

    • Eng FJ, El-Shamy A, Doyle EH, Klepper A, Muerhoff AS, Branch AD. Newly discovered hepatitis C virus minicores circulate in human blood. Hepatol Commun. 2018;2:21-8.
    • Gawlik K, Gallay PA. HCV core protein and virus assembly: what we know without structures. Immunol Res. 2014;60:1-10.
    • Kao CC, Yi G, Huang HC. The core of hepatitis C virus pathogenesis. Curr Opin Virol. 2016;17:66-73.
    • Klein KC, Polyak SJ, Lingappa JR. Unique features of hepatitis C virus capsid formation revealed by de novo cell-free assembly. J Virol. 2004;78:9257-69.
    • Rupp D, Bartenschlager R. Targets for antiviral therapy of hepatitis C. Semin Liver Dis. 2014;34:9-21.
    • Strosberg AD, Kota S, Takahashi V, Snyder JK, Mousseau G. Core as a novel viral target for hepatitis C drugs. Viruses. 2010;2:1734-51.

    E1

    • El Omari K, Iourin O, Kadlec J, et al. Unexpected structure for the N-terminal domain of hepatitis C virus envelope glycoprotein E1. Nat Commun. 2014;5:4874.
    • Haddad JG, Rouillé Y, Hanoulle X, et al. Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly. J Virol. 2017;91:pii: e00048-17.
    • Law JL, Chen C, Wong J, et al. A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans. PLoS One. 2013;8:e59776.
    • Mazumdar B, Banerjee A, Meyer K, Ray R. Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes. Hepatology. 2011;54:1149-56.
    • Moustafa RI, Haddad JG, Linna L, et al. Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain. J Virol. 2018;92:pii: e00939-18.
    • Tong Y, Lavillette D, Li Q, Zhong J. Role of Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly. Front Immunol. 2018;9:1411.
    • Yost SA, Wang Y, Marcotrigiano J. Hepatitis C Virus Envelope Glycoproteins: A Balancing Act of Order and Disorder. Front Immunol. 2018;9:1917.

    E2

    • Albecka A, Montserret R, Krey T, et al. Identification of new functional regions in hepatitis C virus envelope glycoprotein E2. J Virol. 2011;85:1777-92.
    • Drummer HE. Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies. Front Microbiol. 2014;5:329.
    • Fauvelle C, Felmlee DJ, Baumert TF. Unraveling hepatitis C virus structure. Cell Res. 2014;24:385-6.
    • Freedman H, Logan MR, Law JL, Houghton M. Structure and Function of the Hepatitis C Virus Envelope Glycoproteins E1 and E2: Antiviral and Vaccine Targets. ACS Infect Dis. 2016;2:749-762.
    • Khan AG, Whidby J, Miller MT, et al. Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2. Nature. 2014;509:381-4.
    • Kong L, Giang E, Nieusma T, et al. Hepatitis C virus E2 envelope glycoprotein core structure. Science. 2013;342:1090-4.
    • Prentoe J, Velázquez-Moctezuma R, Foung SK, Law M, Bukh J. Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity. Hepatology. 2016;64:1881-92.
    • Sabahi A, Uprichard SL, Wimley WC, Dash S, Garry RF. Unexpected structural features of the hepatitis C virus envelope protein 2 ectodomain. J Virol. 2014;88:10280-8.
    • Vieyres G, Dubuisson J, Pietschmann T. Incorporation of hepatitis C virus E1 and E2 glycoproteins: the keystones on a peculiar virion. Viruses. 2014;6:1149-87.

    P7

    • Atoom AM, Taylor NG, Russell RS. The elusive function of the hepatitis C virus p7 protein. Virology. 2014;462-463:377-87.
    • Chandler DE, Penin F, Schulten K, Chipot C. The p7 protein of hepatitis C virus forms structurally plastic, minimalist ion channels. PLoS Comput Biol. 2012;8:e1002702.
    • Denolly S, Mialon C, Bourlet T, et al. The amino-terminus of the hepatitis C virus (HCV) p7 viroporin and its cleavage from glycoprotein E2-p7 precursor determine specific infectivity and secretion levels of HCV particle types. PLoS Pathog. 2017;13:e1006774.
    • Gentzsch J, Brohm C, Steinmann E, et al. hepatitis c Virus p7 is critical for capsid assembly and envelopment. PLoS Pathog. 2013;9:e1003355.
    • Khaliq S, Jahan S, Hassan S. Hepatitis C virus p7: molecular function and importance in hepatitis C virus life cycle and potential antiviral target. Liver Int. 2011;31:606-17.
    • Madan V, Bartenschlager R. Structural and Functional Properties of the Hepatitis C Virus p7 Viroporin. Viruses. 2015;7:4461-81.
    • OuYang B, Xie S, Berardi MJ, et al. Unusual architecture of the p7 channel from hepatitis C virus. Nature. 2013;498:521-5.

    NS2

    • Jirasko V, Montserret R, Appel N, et al. Structural and functional characterization of nonstructural protein 2 for its role in hepatitis C virus assembly. J Biol Chem. 2008;283:28546-62.
    • Jones CT, Murray CL, Eastman DK, Tassello J, Rice CM. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J Virol. 2007;81:8374-83.
    • Lorenz IC, Marcotrigiano J, Dentzer TG, Rice CM. Structure of the catalytic domain of the hepatitis C virus NS2-3 protease. Nature. 2006;442:831-5.
    • Lorenz IC. The Hepatitis C Virus Nonstructural Protein 2 (NS2): An Up-and-Coming Antiviral Drug Target. Viruses. 2010;2:1635-46.
    • Popescu CI, Callens N, Trinel D, et al. NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly. PLoS Pathog. 2011;7:e1001278.
    • Yi M, Ma Y, Yates J, Lemon SM. Trans-complementation of an NS2 defect in a late step in hepatitis C virus (HCV) particle assembly and maturation. PLoS Pathog. 2009;5:e1000403.

    NS3

    • Brass V, Berke JM, Montserret R, Blum HE, Penin F, Moradpour D. Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex. Proc Natl Acad Sci U S A. 2008;105:14545-50.
    • De Francesco R, Pessi A, Steinkühler C. Mechanisms of hepatitis C virus NS3 proteinase inhibitors. J Viral Hepat. 1999;6 Suppl 1:23-30.
    • Love RA, Parge HE, Wickersham JA, et al. The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell. 1996;87:331-42.
    • Morikawa K, Lange CM, Gouttenoire J, et al. Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus. J Viral Hepat. 2011;18:305-15.
    • Raney KD, Sharma SD, Moustafa IM, Cameron CE. Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target. J Biol Chem. 2010;285:22725-31.
    • Rupp D, Bartenschlager R. Targets for antiviral therapy of hepatitis C. Semin Liver Dis. 2014;34:9-21.

    NS4A

    • Brass V, Berke JM, Montserret R, Blum HE, Penin F, Moradpour D. Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex. Proc Natl Acad Sci U S A. 2008;105:14545-50.
    • Lin C, Wu JW, Hsiao K, Su MS. The hepatitis C virus NS4A protein: interactions with the NS4B and NS5A proteins. J Virol. 1997;71:6465-71.
    • Lindenbach BD, Prágai BM, Montserret R, et al. The C terminus of hepatitis C virus NS4A encodes an electrostatic switch that regulates NS5A hyperphosphorylation and viral replication. J Virol. 2007;81:8905-18.
    • Morikawa K, Lange CM, Gouttenoire J, et al. Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus. J Viral Hepat. 2011;18:305-15.
    • Phan T, Kohlway A, Dimberu P, Pyle AM, Lindenbach BD. The acidic domain of hepatitis C virus NS4A contributes to RNA replication and virus particle assembly. J Virol. 2011;85:1193-204.
    • Zhu H, Briggs JM. Mechanistic role of NS4A and substrate in the activation of HCV NS3 protease. Proteins. 2011;79:2428-43.

    NS4B

    • Esser-Nobis K, Romero-Brey I, Ganten TM, et al. Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B. Hepatology. 2013;57:953-63.
    • Gouttenoire J, Penin F, Moradpour D. Hepatitis C virus nonstructural protein 4B: a journey into unexplored territory. Rev Med Virol. 2010;20:117-29.
    • Lundin M, Lindström H, Grönwall C, Persson MA. Dual topology of the processed hepatitis C virus protein NS4B is influenced by the NS5A protein. J Gen Virol. 2006;87:3263-72.
    • Paul D, Hoppe S, Saher G, Krijnse-Locker J, Bartenschlager R. Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment. J Virol. 2013;87:10612-27.
    • Rai R, Deval J. New opportunities in anti-hepatitis C virus drug discovery: targeting NS4B. Antiviral Res. 2011;90:93-101.

    NS5A

    • Appel N, Zayas M, Miller S, et al. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog. 2008;4:e1000035.
    • Berger C, Romero-Brey I, Radujkovic D, et al. Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication. Gastroenterology. 2014;147:1094-105.e25.
    • Bukh J. The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control. J Hepatol. 2016;65:S2-S21.
    • Dustin LB, Rice CM. Flying under the radar: the immunobiology of hepatitis C. Annu Rev Immunol. 2007;25:71-99.
    • Morozov VA, Lagaye S. Hepatitis C virus: Morphogenesis, infection and therapy. World J Hepatol. 2018;10:186-212.
    • Romero-Brey I, Berger C, Kallis S, et al. NS5A Domain 1 and Polyprotein Cleavage Kinetics Are Critical for Induction of Double-Membrane Vesicles Associated with Hepatitis C Virus Replication. MBio. 2015;6:e00759.
    • Yin C, Goonawardane N, Stewart H, Harris M. A role for domain I of the hepatitis C virus NS5A protein in virus assembly. PLoS Pathog. 2018;14:e1006834.
    • Zayas M, Long G, Madan V, Bartenschlager R. Coordination of Hepatitis C Virus Assembly by Distinct Regulatory Regions in Nonstructural Protein 5A. PLoS Pathog. 2016;12:e1005376.

    NS5B

    • Ago H, Adachi T, Yoshida A, et al. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Structure. 1999;7:1417-26.
    • Appleby TC, Perry JK, Murakami E, et al. Viral replication. Structural basis for RNA replication by the hepatitis C virus polymerase. Science. 2015;347:771-5.
    • Boyce SE, Tirunagari N, Niedziela-Majka A, et al. Structural and regulatory elements of HCV NS5B polymerase--β-loop and C-terminal tail--are required for activity of allosteric thumb site II inhibitors. PLoS One. 2014;9:e84808.
    • Lesburg CA, Cable MB, Ferrari E, Hong Z, Mannarino AF, Weber PC. Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat Struct Biol. 1999;6:937-43.
    • Lohmann V, Roos A, Körner F, Koch JO, Bartenschlager R. Biochemical and structural analysis of the NS5B RNA-dependent RNA polymerase of the hepatitis C virus. J Viral Hepat. 2000;7:167-74.
    • Love RA, Parge HE, Yu X, et al. Crystallographic identification of a noncompetitive inhibitor binding site on the hepatitis C virus NS5B RNA polymerase enzyme. J Virol. 2003;77:7575-81.
    • Mosley RT, Edwards TE, Murakami E, et al. Structure of hepatitis C virus polymerase in complex with primer-template RNA. J Virol. 2012;86:6503-11.
    • Soriano V, Vispo E, de Mendoza C, et al. Hepatitis C therapy with HCV NS5B polymerase inhibitors. Expert Opin Pharmacother. 2013;14:1161-70.
    • Thueng-in K, Thanongsaksrikul J, Jittavisutthikul S, et al. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase. MAbs. 2014;6:1327-39.

    Share by e-mail

    About HCV Biology

    The hepatitis C virus (HCV) biology page provides a highly visual learning format to explore basic concepts related to the biology of HCV. Conceptually, it is important to understand that translation of the HCV RNA results in the production of structural and non-structural proteins and these non-structural proteins are found only inside of hepatocytes. Click on any of the links above to learn more about HCV structure, proteins, or life cycle.

    Editors
    David H. Spach, MD
    H. Nina Kim, MD

    Illustrators
    Jared Travnicek, CMI, Cognition Studio
    David Ehlert, CMI, Cognition Studio

    Reviewers
    Shyamasundaran Kottilil, PhD
    Stephen J. Polyak, PhD